N/A N=150

Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients

Uterine Cervical Neoplasms · Sexually Transmitted Diseases

Bottom Line

View on ClinicalTrials.gov: NCT02401867 ↗

Enrolled (actual)

150

Serious AEs

0.0%

Results posted

Jun 2017

Primary outcome: Primary: Concordance Between Vaginal Self-swab Results and Provider-collected Cervical Swab Results for HPV DNA Among Sexually Active FTM Adults — 15; 2; 6; 108 Participants — p=.29

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult · 21+ yrs
Sex: Female
Sponsor: Fenway Community Health
Primary completion: Sep 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Concordance Between Vaginal Self-swab Results and Provider-collected Cervical Swab Results for HPV DNA Among Sexually Active FTM Adults	15; 2; 6; 108	.29

Summary

The purpose of this study is to assess the acceptability and effectiveness of utilizing vaginal self-swabs for HPV DNA testing as compared to provider-collected cervical swabs for HPV, as well as to investigate the prevalence of other Sexually Transmitted Infections (STIs) among sexually active female-to-male (FTM) transgender adults.

Eligibility Criteria

Inclusion Criteria

Age 21-64
Assigned a female sex at birth and now self-identifies as a man, trans masculine, trans man, FTM, transgender, genderqueer/non-binary, transsexual, male, and/or another diverse transgender identity or expression
Have a cervix
Sexually active in the past 36 months (with sexual partner(s) of any gender)
Able to speak and understand English
Willing and able to provide informed consent

Exclusion Criteria

Unable to provide informed consent due to severe mental or physical illness
Substance intoxication at the time of interview

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02401867). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.